"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to GLSI. [ FAQ on what and how to ask] For non-GLSI questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Snehal S. Patel
Headquarter: Building 14, 3992 Bluebonnet Dr., Stafford, TX, United States, 77477
Industry: Biotechnology, Employees: 4
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
My Watchlist
